Physician profile
Lauren Wirdzek
NPI 1275262164
$3,600.59
in general payments reported to CMS, 2019-2025
36 companies · $1,311 in 2025
The $1,311 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $159 · 2023: $1,241 · 2024: $889 · 2025: $1,311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,441.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $543.65 | 2023-2025 | |
| Novo Nordisk INC | $340.51 | 2022-2025 | Rybelsus, Ozempic |
| Lilly USA, LLC | $325.61 | 2022-2025 | Jardiance, Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $261.51 | 2023-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Janssen Pharmaceuticals, INC | $219.47 | 2023-2025 | Spravato, Xarelto |
| Abbvie INC. | $201.45 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $176.15 | 2023-2025 | |
| Gilead Sciences, INC. | $162.94 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $148.22 | 2022-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $105.72 | 2024-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $96.95 | 2025 | Caplyta |
| Bayer Healthcare Pharmaceuticals INC. | $79.35 | 2023-2024 | |
| Agios Pharmaceuticals, INC. | $77.83 | 2025 | Pyrukynd |
| Merck Sharp & Dohme LLC | $72.70 | 2023-2025 | Gardasil 9, Vaxneuvance, Pneumovax 23 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $71.96 | 2023 | Xifaxan |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $71.13 | 2025 | Gemtesa |
| Corcept Therapeutics | $59.45 | 2025 | Korlym |
| Exact Sciences Corporation | $59.12 | 2023-2025 | Cologuard Collection Kit |
| Bausch Health US, LLC | $57.75 | 2023 | Wellbutrin |
| Scilex Pharmaceuticals INC. | $54.35 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $48.58 | 2022-2023 | Farxiga |
| Amgen INC. | $48.32 | 2024-2025 | Evenity, Prolia |
| Phathom Pharmaceuticals, INC. | $47.71 | 2025 | Voquezna |
| Edwards Lifesciences Corporation | $32.22 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Si-Bone, INC. | $25.67 | 2023 | |
| Ascensia Diabetes Care US INC. | $24.29 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $24.08 | 2022 | |
| Hologic Sales and Service, LLC | $22.43 | 2025 | Aptima |
| Phadia US INC. | $19.66 | 2023 | Immunocap |
| Seqirus USA INC | $19.58 | 2024 | Flucelvax, Fluad |
| Medtronic, INC. | $19.48 | 2024 | Minimed 780g |
| Biohaven Pharmaceutical Holding Company LTD. | $19.41 | 2022 | |
| Verity Pharmaceuticals INC. | $18.19 | 2024 | Tlando |
| Xeris Pharmaceuticals, INC. | $15.75 | 2025 | Gvoke Hypopen |
| Idorsia Pharmaceuticals US INC | $15.15 | 2023 | Quviviq |
| Boston Scientific Corporation | $14.25 | 2024 | General - Therapies |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Wirdzek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.